61
Views
0
CrossRef citations to date
0
Altmetric
Patent Evaluations

Targeted antimicrobial moieties (WO2010080819): patent evaluation

&
Pages 593-600 | Published online: 26 Feb 2011

Bibliography

  • Waksman SA. What is an antibiotic or an antibiotic substance? Mycologia 1947;39(5):565-9
  • Franz von N, Michael B, Berthold H, Antibacterial natural products in medicinal chemistry-exodus or revival? Angew Chem Int Ed 2006;45(31):5072-129
  • Calderon CB, Sabundayo BP. Antimicrobial classifications: drugs for bugs. In: Schwalbe R, Steele-Moore L, Goodwin AC, editors, Antimicrobial Susceptibility Testing Protocols. CRC Press:Taylor & Frances group; 2007
  • Slama TG, Amin A, Brunton SA, A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria. Am J Med 2005;118(Suppl 7A):1S-6S
  • Cowen LE. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Microbiol 2008;6(3):187-98
  • Levy SB. Balancing the drug-resistance equation. Trends Microbiol 1994;2(10):341-2
  • Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008;62(Suppl 1):i1-9
  • Ong S, Nakase J, Moran GJ, Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction. Ann emerg med 2007;50(3):213-20
  • Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3:710-20
  • Hancock REW, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 1998;16:82-8
  • Caroline AG, Lee M, Prasad K, Milwood M. Antimicrobial activity of magainin analogues against anaerobic oral pathogens. Int J Antimicrob Ag 2003;21:75-8
  • He J, Eckert R, Pharm T, Novel Synthetic Antimicrobial Peptides against Streptococcus mutans. Antimicrob Agents Chemother 2007;51:1351-8
  • Kim AB. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005;3:238-50
  • Muhle SA, Tam JP. Design of gram-negative selective antimicrobial peptides. Biochemistry 2001;40:5777-85
  • Tossi A, Sandri L, Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 2000;55:4-30
  • Eckert R, He J, Yarbrough DK, Targeted Killing of Streptococcus mutans by a Pheromone-Guided “Smart” Antimicrobial Peptide. Antimicrob Agents Chemother 2006;50:3651-7
  • Eckert R, Qi FX, Yarbrough DK, Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against pseudomonas spp. Antimicrob Agents Chemother 2006;50:1480-8
  • David A, Goodwin CF, Meares MJ, Pre-targeted immunoscintigraphy of murine tumors with Indium-111-labeled Bifunctional Haptens. J Nucl Med 1988;29:226-34
  • Oehr P, Westermann J, Biersack HJ. Streptavidin and biotin as potential tumor imaging agents. J Nucl Med 1988;29:728-9
  • Klibanov AL, Martynov AV, Slinkin MA, Blood clearance of radiolabeled antibody: enhancement by Lactosamination and treatment with Biotin-Avidin or Anti-Mouse IgG antibodies. J Nucl Med 1988;29:1951-6
  • Hnatowich DJ, Virzi F, Rusckowski M. Investigations of Avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-302
  • Sinitsyn VV, Mamontova AG, Checkneva YY, Rapid blood clearance of Biotinylated IgG after infusion of Avidin. J Nucl Med 1989;30:66-9
  • Kalofonos HP, Rusckowski M, Siebecker DA, Imaging of tumor in patients with Indium-111-labeled Biotin and Streptavidin-conjugated antibodies: preliminary communication. J Nucl Med 1990;31:1791-6
  • Schechter B, Arnon R, Wilchek M, Indirect immunotargeting of CIS-PT to human epidermoid carcinoma KB using the avidin-biotin system. Int J Cancer 1991;48(2):167-72
  • Paganelli G, Magnani P, Zito F, Three-step monoclonal antibody tumor targeting in Carcinoembryonic Antigen-positive patients. Cancer Res 1991;51:5960-6
  • Paganelli G, Malcovati M, Fazio F. Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system. Nucl Med Comm 1991;12(3):211-34
  • O'Connor PM, Wassermann K, Sarang M, Relationship between DNA cross-links, cell cycle, and apoptosis in burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res 1991;51:6550-7
  • Yuan F, Baxter LT, Jain RK. Pharmacokinetic analysis of two-step approaches using bifunctional and enzyme-conjugated antibodies. Cancer Res 1991;51:3119-30
  • Bruchez M, Moronne M, Gin P, Semiconductor nanocrystals as fluorescent biological labels. Science 1998;281:2013-6
  • Warren C, Chan W, Nie SM. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998;218:2016-18
  • Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 1998;42(1):13-28
  • Thomas S, Karnik S, Barai RS, CAMP: a useful resource for research on antimicrobial peptide. Nucleic Acids Res 2009;1-7
  • Bondi ML, Fontana G, Carlisi B, Preparation and characterization of solid lipid nanoparticles (SLN) containing cloricromene. Drug deliv 2003;10:245-50
  • Pedersen N, Hansen SE, Heydenreich AV, Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 2006;62:155-62
  • Shiokawa T, Hattori Y, Kawano K, Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin a on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res 2005;11:2018-25
  • Eppstein DA, Marsh YV, van der Pas M, Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor. P Natl Acad Sci USA 1985;82(11):3688-92
  • Hwang KJ, Luk KF, Beaumier PL. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. P Natl Acad Sci USA 1980;77(7):4030-4
  • Matsumoto J, Nakada Y, Sakurai K, Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evaluation in vitro. Int J Pharm 1999;185:93-101
  • Chawla JS, Amiji MM. Biodegradable poly (epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127-38
  • Williams J, Lansdown R, Sweitzer R, Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J Control Release 2003;91:167-72
  • Leroux JC, Allemann E, De Jaeghere F, Biodegradable nanoparticles -from sustained release formulations to improved site specific drug delivery. J Control Release 1996;39:339-50
  • Soppimath KS, Aminabhavi TM, Kulkarni AR, Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20
  • Papagianni M. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol Adv 2003;21:465-99
  • Durr UHN, Sudheendra US. Ayyalusamy Ramamoorthy, LL-37, the only human member of the cathelicidin family of antimicrobial peptides. BBA-Biomembranes 2006;1758:1408-25

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.